A system for medication management
The integration of biometric authentication with real-time physiological data acquisition in medication dispensing systems addresses the challenge of ensuring appropriate patient condition for medication administration, enhancing safety and adherence by verifying user identity and physiological parameters before dispensing.
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-10-04
- Publication Date
- 2026-04-09
AI Technical Summary
Existing medication management systems fail to ensure that a patient's physiological condition is appropriate for medication administration at the precise moment of dispensing, lacking the capability to mandatorily acquire and evaluate real-time physiological data as a prerequisite for dispensing.
A medication dispensing system that integrates biometric authentication with real-time physiological data acquisition, ensuring medications are dispensed only after successful verification of both user identity and physiological parameters within acceptable ranges, using a control unit to manage and evaluate the data before initiating a dispensing cycle.
Ensures safe and context-aware medication administration by verifying user identity and physiological status contemporaneously, preventing dispensing when conditions are not met, and providing auditable records for clinical oversight.
Smart Images

Figure IB2025060026_09042026_PF_FP_ABST
Abstract
Description
[0001] TITLE: A SYSTEM FOR MEDICATION MANAGEMENT
[0002] TECHNICAL FIELD
[0003] The present disclosure relates generally to automated medication dispensing systems. More particularly, the disclosure relates to a medication dispensing system that requires acquisition of physiological data from a user as a prerequisite for medication dispensing, and methods for controlling medication access based on real-time physiological parameters and biometric authentication.
[0004] BACKGROUND
[0005] Medication non-adherence represents a significant challenge in healthcare, with studies indicating that 50-75% of patients fail to adhere to prescribed medication regimens, particularly in chronic diseases such as diabetes, hypertension, and mental health disorders. Non-adherence leads to suboptimal therapeutic outcomes, increased healthcare costs, and in severe cases, life-threatening complications including medication overdoses and treatment failures.
[0006] Traditional approaches to medication management have focused primarily on automated dispensing based on predetermined schedules, user authentication, and adherence monitoring. However, these systems typically lack the capability to assess whether a patient's physiological condition is appropriate for medication administration at the time of dispensing.
[0007] Several prior art systems demonstrate various approaches to medication management and monitoring:
[0008] Prior Art CN118553376A discloses an intelligent medication management system that combines a smart pillbox with mobile applications and cloud-based analytics. The system utilizes machine learning algorithms including logistic regression and collaborative filtering to predict user medication adherence patterns based on historical usage data, health parameters, and user behavior. While the system collects physiological data such as blood pressure and blood glucose levels, this data is used primarily for adherence analysis and personalized recommendations rather than as a prerequisite for medication dispensing. The system operates on scheduled dispensing with user authentication but does not require physiological data acquisition before each dispensing event. Prior Art IN202141002260A describes a smart medication system for real-time monitoring of elderly and chronic patients, incorporating bio-sensors for continuous monitoring of physiological and biochemical parameters including heart rate, blood pressure, ECG, oxygen saturation level, and temperature. The system includes an loT- enabled smart capsule kit with multiple compartments organized by medication types. However, the physiological monitoring functions operate independently of the medication dispensing mechanism, serving primarily for health tracking and caregiver alerts rather than as a conditional requirement for medication access.
[0009] Prior Art IN202341073404A teaches an automated intelligent medicine dispensary system featuring biometric authentication through fingerprint recognition for secure access to medication compartments. The system includes a medication data processing module that analyzes patient medication history, vital signs, and lifestyle factors to generate personalized recommendations. While the system incorporates analysis of vital signs data, this information is used for treatment optimization and reporting purposes, and the medication dispensing function operates based on scheduled timing and successful biometric authentication rather than requiring real-time physiological data acquisition as a prerequisite for dispensing.
[0010] Despite these advances in medication management technology, existing systems fail to address a critical gap: the inability to ensure that a patient's physiological condition is appropriate for medication administration at the precise moment of dispensing. Current systems either monitor physiological parameters independently of dispensing events or use such data retrospectively for adherence analysis and treatment adjustments.
[0011] There remains a need for a medication dispensing system that mandatorily acquires and evaluates physiological data immediately prior to each dispensing event, thereby providing an additional layer of safety by ensuring that medication is only dispensed when the patient's physiological parameters are within acceptable ranges or when such data has been successfully captured for clinical monitoring purposes.
[0012] Here is the previously generated summary annotated with claim numbers in parentheses at appropriate places to show coverage:
[0013] SUMMARY
[0014] The present disclosure relates generally to physiologically-gated medication dispensing systems, and more particularly, to a medication dispensing system and method that mandatorily acquires non-invasive physiological data as a prerequisite for medication dispensing and integrates biometric authentication to ensure user-specific medication delivery at the point of administration.
[0015] It is an object of the present disclosure to provide an improved medication dispensing system comprising a medication dispensing device, at least one physiological data recording sensor, and a control unit that receives physiological data prior to initiating a dispensing cycle, utilizes the data for transmission, storage, or evaluation, and initiates dispensing only after the physiological data has been obtained. Moreover, the present disclosure relates to a system in which the physiological data is optionally compared against predefined conditions to prevent dispensing when safety thresholds are not met, and biometric authentication ensures that physiological data and medication access are tied to the same authenticated user during a common acquisition event.
[0016] This object is achieved by the features of the various aspects of the disclosure described herein. Further implementation forms are apparent from the description.
[0017] According to a first aspect, there is provided a medication dispensing system comprising a medication dispensing device configured to store and release at least one medication, at least one physiological data recording sensor configured to non-invasively obtain physiological data of a user, and a control unit operatively coupled to both components, wherein the control unit receives the physiological data prior to initiating a dispensing cycle, utilizes the data for at least one of transmitting, storing, or evaluating, and initiates dispensing only after the physiological data has been obtained, optionally generating a notification based on the physiological data.
[0018] According to a second aspect, there is provided a method of controlled dispensing comprising acquiring physiological data of a user through at least one physiological data recording sensor, utilizing the physiological data for at least one of transmitting, storing, or evaluating, and dispensing medicines only after the physiological data has been obtained.
[0019] Preferably, the control unit is configured to compare the physiological data with at least one predefined condition and to prevent activation of the medication dispensing device when the condition is not satisfied, wherein the predefined condition comprises at least one of heart / pulse rate variability, oxygen saturation, heart rate, body temperature, or blood pressure. Preferably, the control unit authenticates the user via biometric input selected from fingerprint recognition, facial recognition, or voice recognition, and permits activation only upon successful authentication.
[0020] In preferred embodiments, at least one sensor module acquires both biometric authentication data and physiological data through a common sensing channel, ensuring both are captured from the same person during a common acquisition event, and in a particularly preferred embodiment the common sensing channel comprises a fingerprint slot housing both a fingerprint sensor and at least one physiological data recording sensor to obtain both data types from the same finger placement event. The control unit assigns a session identifier and timestamp to the biometric authentication event, acquires physiological data within a predefined time interval following authentication, and permits dispensing only when both are associated with the same session identifier and fall within the time interval.
[0021] Preferably, the medication dispensing device comprises one or more cartridges each configured to store a plurality of pills in a stacked arrangement, with the control unit selecting at least one cartridge based on a prescribed medication schedule to dispense medicines in accordance with the schedule, wherein each cartridge comprises a linear slot, a feeder gear assembly with a feeder lever arranged to advance only a single pill per dispensing cycle, and a mechanical stopper or gate positioned adjacent the outlet to block release of more than one pill at a time.
[0022] In preferred implementations, each cartridge further comprises at least one dispense sensor disposed at a dispensing opening to detect passage of a dispensed pill and provide a confirmation signal to validate completion of the dispensing cycle, with the control unit configured to inhibit dispensing if the dispense sensor does not detect pill presence within a predetermined time or detects simultaneous dispensing of more than one pill. The control unit activates a feedback unit after dispensing, comprising predefined input buttons for patient status selection, a microphone for voice recording, or a camera for image capture, optionally configured to operate for a predefined duration and automatically deactivate if no input is received.
[0023] The device and system described herein provide a physiologically-gated, identity-bound medication access platform that ensures medications are dispensed only to authenticated users whose contemporaneous physiological status has been captured and optionally verified against safety conditions, with single-pill mechanical control and electronic confirmation for auditable administration events. Therefore, in contradistinction to existing schedule-based dispensers, biometric-only access systems, or platforms that monitor physiology independently of dispensing, the disclosed system offers a tightly integrated approach that mandatorily acquires physiological data immediately before each dispensing cycle, binds this data to successful biometric authentication of the intended user, and constrains dispensing through cartridge architecture with single-pill feed mechanisms, dispense sensors, and inhibit logic to prevent dispensing errors while providing comprehensive session tracking and optional post-dispensing feedback collection.
[0024] To enable safe, context-aware, patient-specific medication administration across diverse healthcare settings — particularly for high-risk therapies requiring physiological monitoring — while providing auditable records of contemporaneous physiological data, authenticated user identity, session linkage, and confirmed dispensing events for clinical oversight and telehealth applications.
[0025] These and other aspects of the disclosure will be apparent from the implementation(s) described below.
[0026] BRIEF DESCRIPTION OF DRAWINGS
[0027] Implementations of the disclosure will now be described, by way of example only, with reference to the accompanying drawings, in which:
[0028] FIG. 1 is a system architecture overview showing the three primary interconnected components of the medication dispensing system.
[0029] FIG. 2 is a component module architecture illustrating the comprehensive array of electronic and mechanical components integrated within the device.
[0030] FIG. 3 is an external device configuration presenting an exterior view of the device showing the integrated common sensing channel.
[0031] FIG. 4 is an internal mechanism and component layout revealing the detailed internal architecture of the medication dispensing device.
[0032] FIG. 5 is an integrated biometric and physiological sensing interface detailing the critical common sensing channel for dual authentication and data acquisition.
[0033] FIG. 6 is a cartridge design and dispensing mechanism illustrating the detailed construction and operational principles of the pill cartridges. FIG. 7 is a patient sub-system architecture showing the primary interface through which patients interact with the medication dispensing system.
[0034] FIG. 8 is a caregiver sub-system architecture detailing the comprehensive oversight and management capabilities for authorized caregivers.
[0035] FIG. 9 is a healthcare professional sub-system architecture illustrating the comprehensive patient management and decision support capabilities for clinical practitioners.
[0036] FIG. 10 is a method of physiologically -gated medication dispensing showing the systematic operational flowchart of the controlled dispensing process.
[0037] DETAILED DESCRIPTION
[0038] Implementations of the present disclosure provide an improved physiologically-gated medication dispensing system for automated medication management, integrating biometric authentication with real-time physiological data acquisition, supported by precision cartridge dispensing mechanisms that enable secure single-pill delivery. The system includes a medication dispensing device designed to store and release medications, a control unit with physiological data recording sensor and biometric sensors for user authentication and vital signs monitoring, and cloud-based server integration to enhance medication adherence and clinical oversight. The design ensures comprehensive medication safety, identity-bound access control, and contemporaneous physiological monitoring for patients during medication administration in home healthcare settings, assisted living facilities, clinical environments, or the like. To make the details of the present disclosure more comprehensible for a person skilled in the art, the following embodiments are described with reference to the accompanying drawings.
[0039] Terms such as "a first," "a second," "a third," and "a fourth" if any in the summary, claims, and foregoing accompanying drawings of the present disclosure are used to distinguish between similar components or features and are not necessarily used to describe a specific sequence or order. It should be understood that the terms so used are interchangeable under appropriate circumstances, so that the implementations of the present disclosure described herein are, for example, capable of being implemented in configurations other than those illustrated or described herein. Furthermore, the terms "include," "comprise," and "have" and any variations thereof, are intended to cover a non-exclusive inclusion. For example, a device, a system, a method, or a component that includes a series of elements or steps is not necessarily limited to expressly listed elements or steps but may include other elements or steps that are not expressly listed or that are inherent to such device, system, method, or component.
[0040] Definitions
[0041] As used herein, the term "user" refers to any individual who interacts with the medication dispensing system, including but not limited to a patient, caregiver, or healthcare professional who may access the system for medication dispensing, monitoring, or management purposes.
[0042] As used herein, the term "patient" refers to an individual who is prescribed medication and for whom the medication dispensing system is configured to provide controlled access to such medication, including the individual who directly receives and consumes the dispensed medication.
[0043] As used herein, the term "caregiver" refers to an individual authorized to assist, monitor, or oversee a patient's medication management, including but not limited to family members, professional caregivers, nursing staff, or other authorized personnel responsible for patient care.
[0044] As used herein, the term "healthcare professional" refers to a licensed medical practitioner, including but not limited to physicians, nurses, pharmacists, or other clinical personnel involved in prescribing, monitoring, or managing patient medication therapy.
[0045] The present disclosure relates to a physiologically-gated medication dispensing system that mandatorily acquires non-invasive physiological data as a prerequisite for medication dispensing and integrates biometric authentication to ensure user-specific medication delivery. The system comprises a medication dispensing device that collects real-time physiological parameters such as heart (or pulse) rate variability (HRV), oxygen saturation (SpCh), etc., through integrated sensors during the authentication process, thereby creating a direct temporal and identity linkage between the authenticated user and their physiological status at the point of medication access. This approach ensures that medications are dispensed only after successful biometric verification and contemporaneous physiological data acquisition, with optional evaluation against predefined safety conditions, while maintaining comprehensive session tracking and auditable dispensing records for clinical oversight and remote monitoring applications.
[0046] System Architecture Overview Referring to FIG. 1, the medication dispensing system 10 comprises three primary interconnected components that work in coordination to provide comprehensive medication management with integrated physiological monitoring. The medication dispensing device 12 serves as the central hardware unit that physically stores, controls access to, and dispenses medications while simultaneously capturing biometric authentication data and physiological parameters from users. The cloud-based server system 14 provides centralized data processing, storage, analysis, and coordination services, enabling real-time communication between system components, healthcare provider access, and long-term trend analysis of medication adherence and physiological responses. The server system 14, in one embodiment, further incorporates comprehensive financial management capabilities that track, analyze, and report medication-related expenses to support budget planning and healthcare cost management for patients, caregivers, and healthcare providers. A client system 16 encompasses user-facing applications and interfaces that allow patients, caregivers, and healthcare professionals to interact with the system, configure medication schedules, monitor adherence, and access physiological data records.
[0047] Data pathways 18 facilitate comprehensive communication between all system 10 components. The data pathway 18 between the device 12 and the server system 14 enables the device 12 to transmit physiological data, authentication records, dispensing logs, system status, medication cost data, and financial transaction records, etc., upstream to the server system 14, while receiving medication schedules, configuration updates, authorization commands, safety protocols, budget alerts, and expense notifications, etc., downstream from the server system 14. The pathway 18 between the server system 14 and the client system 16 allows the server system 14 to deliver patient data, analytical reports, system alerts, and historical records to client interfaces, while accepting user inputs, schedule configurations, access permissions, and monitoring requests from the client applications. The direct data pathway 18 between the client system 16 and the device 12 provides immediate communication for real-time commands, emergency overrides, and local configuration changes from the client to the device 12, while enabling the device 12 to send instant status updates, alarm notifications, and confirmation signals directly to the client interface.
[0048] This three-tier system 10 architecture ensures that physiological data acquisition occurs locally at the point of medication access through the device 12, while enabling secure transmission and centralized analysis through the server system 14, and providing accessible interfaces for various stakeholders through the client system 16. The integration of these components creates a seamless workflow where medication dispensing is contingent upon successful completion of both biometric authentication and physiological data capture, with all events logged and transmitted for comprehensive monitoring and analysis.
[0049] Health News and Critical Alert Distribution Network
[0050] In one embodiment, the cloud-based server system 14 incorporates a comprehensive health news and critical alert distribution network that enables healthcare authorities, medical institutions, and authorized healthcare providers to disseminate important health- related information, emergency medical alerts, and safety notifications directly to patients, caregivers, and healthcare professionals through the medication dispensing system 10. This distribution network monitors verified medical information sources, including public health agencies, FDA safety communications, pharmaceutical manufacturers' safety alerts, and clinical research findings, automatically filtering and categorizing health news based on relevance to individual patient medical profiles and current medication regimens. When critical health information is identified — such as medication recalls, drug interaction warnings, disease outbreak alerts, or updated treatment protocols — the system generates targeted notifications that are transmitted through all available communication channels including the display 36, speaker 38, and mobile applications within the client system 16. The health news distribution capability enables real-time dissemination of medication safety updates, allowing patients to receive immediate notifications about potential risks or benefits related to their specific medications, while healthcare professionals can broadcast important clinical updates, treatment modifications, or emergency health advisories directly to their patient populations. This integrated approach ensures that all stakeholders in the medication management ecosystem remain informed of critical health developments that may impact treatment decisions, medication safety, or patient care protocols, thereby enhancing the overall safety and effectiveness of the medication management process through timely access to relevant medical information and emergency health communications.
[0051] Component Module Architecture
[0052] FIG. 2 illustrates the comprehensive array of electronic and mechanical components integrated within the device 12 to enable physiologically-gated medication access with biometric authentication. The system is built upon a printed circuit board (PCB) 19 that serves as the foundational platform connecting and housing all electronic components within the device architecture.
[0053] A fingerprint sensor(s) 20 provides biometric identity verification, working in coordination with a physiological data recording sensor(s) 22 that capture vital parameters including heart (or pulse) rate variability (HRV) and oxygen saturation (SpCb) through non-invasive contact during the authentication process. In alternative embodiments, the biometric authentication system incorporates multiple authentication modalities including iris / retinal scanning sensors integrated within the common sensing channel for optical biometric verification, palm print recognition systems featuring larger sensing surfaces that accommodate full palm placement for both authentication and physiological monitoring, and voice recognition modules requiring spoken passphrase authentication before physiological data acquisition. The system further supports multimodal biometric authentication through sequential authentication protocols (voice —> facial —> physiological) or parallel authentication systems (facial + physiological simultaneously) to enhance security and reliability of user verification.
[0054] The processor 24 serves as the central control unit that coordinates all system functions, processes biometric and physiological data, implements dispensing logic, manages medication cost calculations, tracks financial transactions, and manages communication protocols. Notably, at times, the terms ‘control unit’ and the ‘processor’ 24 are used interchangeably in the present disclosure. In some embodiments, the processor 24 incorporates advanced machine learning evaluation algorithms that learn individual baseline physiological patterns for personalized threshold determination, enabling comparative analysis through real-time comparison against user's historical physiological patterns. The system, in some embodiments, implements medication-specific evaluation protocols with different evaluation criteria based on specific medication contraindications, time-of-day adjustments for circadian rhythm-aware threshold modifications, and progressive monitoring systems that base evaluation on trends rather than single-point measurements.
[0055] Communication capabilities are provided through multiple channels including a Bluetooth module 26 for local device connectivity, a Wi-Fi module 28 for internet connectivity, and a SIM circuit 30 working with an antenna 32 for cellular data transmission, ensuring reliable data transmission to the server system 14 regardless of local connectivity conditions. The medication dispensing system 10 incorporates comprehensive external medical device integration capabilities that enable the processor 24 to gather supplementary physiological and health parameter information from compatible third-party medical monitoring devices. The system supports interoperability with commonly used home medical devices including digital thermometers, automated blood pressure monitors, pulse oximeters, glucometers, and other FDA-approved medical measurement devices through standardized communication protocols including Bluetooth Low Energy (BLE), USB connectivity, and proprietary medical device interfaces. The system, in some embodiments, further integrates with wearable sensor devices including fitness trackers and smartwatches to accept physiological data from pre-worn monitoring devices, incorporating breath analysis sensors for alcohol or glucose detection through breath before medication access, and supporting contact-free physiological monitoring through radar or optical sensors that measure vital signs without physical contact.
[0056] The processor 24 is configured to automatically detect and establish connections with authorized medical devices within the local environment, enabling the system to acquire supplementary vital signs data including body temperature measurements, systolic and diastolic blood pressure readings, blood glucose levels, and additional oxygen saturation readings to complement the physiological parameters captured through the integrated physiological data recording sensor(s) 22. This external device integration capability enhances the comprehensive health monitoring functionality by providing healthcare professionals with a more complete physiological profile at each medication dispensing event, enabling improved clinical decision-making and treatment optimization based on multiple concurrent health parameters. The integrated data from external medical devices is synchronized with the session identifier and timestamp established during the biometric authentication process, ensuring temporal correlation between medication dispensing events and comprehensive physiological assessments, with all external device data transmitted to the cloud-based server system 14 alongside the native sensor measurements for comprehensive clinical analysis and long-term health trend monitoring.
[0057] A GPS module integrated within the device architecture provides comprehensive location tracking and geofencing capabilities for enhanced patient safety and monitoring. The GPS module enables real-time location determination of the medication dispensing device, supporting several critical functions including patient location verification during medication dispensing events, emergency response coordination when adverse events are detected, and geofencing alerts when patients travel outside predefined safe zones. The GPS functionality coordinates with the processor 24 to timestamp medication dispensing events with precise location data, enabling healthcare providers and caregivers to track medication adherence patterns in relation to patient mobility and daily routines. In emergency situations where physiological parameters exceed safety thresholds or when medication dispensing failures occur, the GPS module automatically transmits the device's precise coordinates to emergency contacts and healthcare providers through the cellular communication system. The location data is encrypted and transmitted to the cloud-based server system for integration with patient monitoring dashboards, allowing caregivers to track patient movement patterns and ensure medication compliance across different locations while maintaining patient privacy and data security protocols.
[0058] The memory 34 component stores user profiles, physiological data, medication schedules, medication pricing information, expense records, budget parameters, and system logs locally before transmission to external systems. User interaction is facilitated through a display 36 that shows system status, medication information, cost summaries, budget alerts, and user prompts, while audio communication is provided through a speaker 38 for alarms and notifications and a microphone 40 for voice-based feedback recording.
[0059] The medication dispensing system 10 further incorporates dedicated counter circuits integrated within the processor 24 architecture that provide precise pill counting capabilities for each individual cartridge 58. These counter components continuously track and record the number of pills dispensed from each cartridge through coordination with the dispense sensors 62, maintaining accurate real-time inventory counts that enable precise medication stock monitoring and automated reorder threshold detection. The counter functionality operates through a combination of sensor-triggered event counting and mechanical position tracking, ensuring that each pill dispensing event is accurately logged and that the remaining pill count for each cartridge 58 is continuously updated within the memory 34. This counter-based inventory tracking system provides the foundational data for the automated inventory management protocols, enabling the processor 24 to generate precise restocking alerts and maintain comprehensive medication usage logs for clinical oversight and adherence monitoring purposes.
[0060] Environmental monitoring is accomplished through temperature / humidity sensors 42 that ensure proper medication storage conditions, while LEDs 44 provide visual status indicators for system operation, charging status, and alarm conditions. Motors 46 control the mechanical dispensing mechanisms, while switches 48 enable manual system control and emergency access functions. Power management is handled through a rechargeable battery 50 system with USB 52 connectivity for charging and / or data transfer, and a camera 54 provides additional biometric authentication capabilities through facial recognition and enables teleconsultation features.
[0061] The system, in alternative embodiments, incorporates physiological sensor configurations including temperature-based gating systems with infrared temperature sensors requiring normal body temperature before dispensing, blood pressure integration through cuffbased or cuffless BP measurement as a prerequisite for medication access, and multiparameter sensor arrays combining ECG electrodes, temperature, and pressure sensors in a single interface. The device further supports modular sensor architecture with interchangeable sensor modules for different physiological parameters, distributed sensing networks with multiple small sensors throughout the device housing, and redundant sensor systems with multiple sensors measuring the same parameters for verification and reliability enhancement.
[0062] The camera 54 further incorporates comprehensive disease progression monitoring and visual documentation capabilities that enable systematic tracking of patient health status changes over time. The camera system is configured to capture high-resolution images of visible medical conditions, including but not limited to wound healing progression, skin condition monitoring, physical therapy recovery assessment, and visible symptom documentation such as swelling reduction or improvement in mobility range. The processor 24 coordinates with the camera 54 to automatically timestamp and geo-tag captured images with corresponding session identifiers that link visual documentation to concurrent physiological data recordings from the physiological data recording sensor 22, thereby creating comprehensive medical records that correlate visual progression with quantitative health parameters.
[0063] The visual documentation system operates through both automated capture triggers initiated during medication dispensing events and user-directed capture sessions accessible through manual activation controls, enabling patients to document health status changes at prescribed intervals or when significant changes are observed. All captured disease progression images are automatically encrypted and transmitted to the cloudbased server system 14 through available communication channels, where they are integrated with the patient's comprehensive medical record and made accessible to authorized healthcare professionals through the healthcare professional sub-system 140. The visual documentation capability supports clinical decision-making by providing healthcare providers with objective visual evidence of treatment efficacy, enabling more precise adjustments to medication regimens and therapeutic interventions based on documented progression patterns rather than relying solely on subjective patient reporting or infrequent clinical examinations.
[0064] External Device Configuration
[0065] FIG. 3 presents an isometric exterior view of the device 12 showing the integrated common sensing channel 56 that combines biometric authentication and physiological data acquisition in a unified interface. The device 12 housing incorporates the display 36 for user interaction and system status communication, while pill medication dispensing cartridges 58 are positioned for easy access and loading. The exterior design emphasizes the integrated nature of the sensing interface, where users interact with a single contact point that simultaneously performs identity verification and physiological parameter capture, ensuring that both authentication and vital signs data are obtained from the same individual during the same interaction event.
[0066] This unified sensing approach eliminates the possibility of credential spoofing or mismatched physiological data attribution, as the biometric authentication and physiological monitoring occur simultaneously through the same physical interface. The device 12 exterior is designed to clearly guide users to the common sensing channel 56, ensuring consistent and proper sensor contact for reliable data acquisition.
[0067] Internal Mechanism and Component Layout
[0068] FIG. 4 illustrates the detailed internal architecture of the device 12, revealing the sophisticated mechanical and electronic systems that enable precise medication delivery. The medication dispensing device 12 is architecturally divided into a main dispensing unit and multiple detachable cartridges 58, with the main dispensing unit comprising a plurality of cartridge receiving bays 59 configured to securely accommodate and interface with the individual cartridges 58. The system supports alternative dispensing device architectures including blister pack dispensers for direct dispensing from pharmaceutical blister strips without cartridge transfer, liquid medication systems with physiologically-gated pumps for liquid medications with precise dose measurement, powder / granule dispensers with weight-based dispensing of powder medications after physiological verification, and multi-form dispensers capable of handling tablets, liquids, and inhalers with format-specific dispensing mechanisms. The architecture further incorporates modular dispensing units with interchangeable dispensing modules for different medication types, enabling comprehensive medication management across diverse pharmaceutical presentations. The cartridges 58 form the core storage component of the device 12, designed as removable modules that interface seamlessly with the main dispensing unit. These cartridges 58 are positioned strategically within the dedicated cartridge receiving bays 59 of the main dispensing unit, where they establish both mechanical and electrical connections with the dispensing mechanism through precisely engineered alignment systems.
[0069] The cartridge-to-device interface is maintained through the Neodymium Magnets 60, which provides strong magnetic coupling between the removable cartridges 58 and the cartridge receiving bays 59 of the main dispensing unit. This magnetic attachment system ensures stable positioning during operation while allowing easy cartridge replacement when medication refills are required.
[0070] The device 10 further comprises one or more optical dispense sensors 62 per cartridge 58 that serve as a critical verification component, positioned strategically along a pill dispensing pathway to confirm successful pill release from the cartridges 58 and detect potential jams or dispensing failures. The dispensing sensors 62 monitors the transition point where medications leave the cartridge environment and enter the main dispensing pathway. Preferably the optical dispenser comprises an infrared (IR) dispense sensor.
[0071] The pill drain pathway 64 forms the primary conduit through which medications travel from the cartridges 58 to a collection area 66, utilizing gravity-assisted flow to ensure reliable pill delivery. The drain pathway 64 interfaces directly with the pill outlet of the cartridge 58, which serves as the final dispensing point where medications are collected by users. In some embodiments, a removable collection cup is positioned at the collection area to receive dispensed pills, providing a convenient container for users to collect their pills. In one embodiment, the device 12 incorporates a sensor positioned at the collection area to detect the presence of the collection cup, sending status signals to the device's control unit for tracking and logging purposes. However, the cup remains optional, as the outlet itself is designed to securely hold dispensed pills even when the cup is absent, ensuring continuous operation and user convenience regardless of cup placement.
[0072] The common sensing channel 56 integrates both biometric authentication and physiological monitoring capabilities, housing dual sensors that simultaneously verify user identity and capture vital signs such as heart / pulse rate variability and oxygen saturation. This dual-function design ensures secure access while gathering essential health data before cartridge activation. At the heart of the cartridge-dispensing interface lies the feeder gear assembly 68, which houses the motor-driven components responsible for actuating the dispensing process. The main dispensing unit incorporates a plurality of feeder gear assemblies 68, with the total number of feeder gear assemblies 68 being equal to the total number of cartridge receiving bays and corresponding cartridges 58, thereby providing dedicated dispensing mechanisms for each individual cartridge 58 within the system. The system incorporates alternative dispensing control mechanisms including pneumatic dispensing systems utilizing air-pressure based pill movement and dispensing, vibration-based dispensing with ultrasonic vibration for precise pill positioning and release, gravity- assisted systems with smart electronically controlled gates in gravity-feed systems, rotary dispensing mechanisms with rotating chambers and physiologically-gated release, and electromagnetic dispensing systems utilizing magnetic field manipulation of specially coated medications.
[0073] A feeder lever 70 extends from this assembly, culminating in a lever head 72 thereof that physically contacts and displaces individual pills from their cartridges 58 through a rear access port 74 of the cartridge 58.
[0074] The electrical infrastructure of the device 12 comprises a voltage and current controller module 76 for power regulation and a control circuit (implemented on the PCB 19) for processing logic and system coordination. Communication capabilities are provided through the GSM Antenna 32 and GSM Module 78, enabling cellular connectivity for cloud-based data transmission and remote monitoring. Audio functionality is delivered through the speaker 38 for alarms, notifications, and voice prompts, while the battery 50 provides reliable power storage and management, ensuring continuous operation of the device 12 even during power interruptions.
[0075] Integrated Biometric and Physiological Sensing Interface
[0076] FIG. 5 details the critical common sensing channel that requires both biometric authentication and physiological data acquisition as prerequisites for medication access. The fingerprint scanner 20 provides secure identity verification, while the physiological data sensor 22 simultaneously capture vital physiological parameters including oxygen saturation (SpCh) and heart / pulse rate variability during the same finger contact event.
[0077] In a preferred embodiment, the common sensing channel 56 is configured as a rectangular-shaped interface chamber that houses both sensor elements within a single physical enclosure. The system incorporates alternative common sensing channel configurations including spherical sensing chambers with globe-shaped interfaces accommodating multiple finger positions, sliding contact interfaces with linear tracks requiring finger movement while capturing both biometric and physiological data, pressure-activated platforms with large surface areas requiring palm placement with embedded sensor arrays, wearable sensing interfaces with removable sensor units that attach to user's wrist / finger during dispensing, and touchscreen integration with display screens incorporating embedded biometric and physiological sensors.
[0078] The fingerprint sensor 20 and the physiological data sensor 22 are positioned horizontally along the bottom surface of the rectangular channel, creating a unified sensing platform that allows the user to simultaneously place their fingertip in contact with both sensor surfaces during a single finger placement action. This horizontal coplanar arrangement of the dual sensors within the common sensing channel 56 ensures optimal finger-to-sensor contact geometry and facilitates concurrent data acquisition from both authentication and physiological monitoring systems.
[0079] This integrated dual-sensor configuration ensures that biometric authentication data and physiological measurements are captured from the same individual during a single interaction, eliminating the possibility of credential spoofing or misattributed vital signs data. The sensors are positioned within the same physical interface to guarantee temporal and identity linkage between authentication and physiological monitoring, with both data types assigned the same session identifier and timestamp for comprehensive tracking and clinical correlation.
[0080] The pill outlet is positioned to receive dispensed medications only after successful completion of both biometric verification and physiological data capture, ensuring that medication access is contingent upon satisfactory completion of both authentication and vital signs acquisition. This configuration enables the system to verify user identity, capture contemporaneous health status, and optionally evaluate physiological parameters against predefined safety conditions before authorizing medication dispensing.
[0081] Cartridge Design and Dispensing Mechanism
[0082] FIGS. 6A through 6D illustrate the detailed construction and operational principles of the pill cartridges 58 that enable precise single-pill dispensing with electronic confirmation and anti-jamming mechanisms. Each cartridge 58 exhibits a preferably substantially rectangular configuration with distinct geometric features optimized for secure medication storage and controlled dispensing operations. Cartridge Geometric Configuration and Component Integration
[0083] The cartridge 58 comprises a pill inlet cover 80 positioned at the top surface thereof, which provides selective access to an internal linear slot 81 extending vertically downward through the cartridge body. The linear slot 81 is dimensioned to accommodate pills in a vertically stacked configuration, with the slot geometry ensuring proper pill alignment and preventing lateral displacement during storage and dispensing operations.
[0084] A transparent front panel 82 is integrated into the front face of the cartridge 58, extending substantially across the width and height of the storage chamber, thereby enabling direct visual verification of pill quantity, type, and arrangement within the linear slot 81. This transparent panel 82 facilitates user confirmation of proper medication loading and remaining inventory without requiring cartridge removal or disassembly.
[0085] The rear surface of the cartridge 58 incorporates a rear access port 74, which is precisely positioned and dimensioned to enable mechanical interface with the feeder lever 70 of the feeder gear assembly 68. The rear access port 74 provides controlled access for the lever head 72 to engage with individual pills during the dispensing sequence while maintaining structural integrity of the cartridge assembly.
[0086] Dispensing Control and Anti-Jamming Mechanisms
[0087] A rubber stopper 84 is strategically positioned within the internal linear slot 81, functioning as a critical mechanical gate that prevents simultaneous release of multiple pills during each activation cycle. The bottom portion of the cartridge 58 features a pill outlet 86 through which individual pills are released following successful dispensing activation. The pill outlet 86 is aligned with the pill drain pathway 64 to ensure direct medication transfer to the collection area 66 without spillage or misdirection.
[0088] Cartridge Alignment and Magnetic Attachment System
[0089] A linear guide 88 is disposed on the external bottom surface of the cartridge 58, providing precise mechanical alignment with corresponding guide channels in cartridge receiving bays 59 of the main dispensing unit. The linear guide 88 prevents lateral movement, rotational displacement, and misalignment during cartridge insertion, operation, and removal, thereby ensuring consistent positioning relative to the feeder mechanism and dispensing pathway. The cartridge 58 incorporates a first neodymium magnet 60 positioned at the base thereof, which provides secure magnetic coupling with a corresponding second neodymium magnet located within the cartridge receiving bay 59. This dual-magnet configuration creates a strong attractive force that maintains stable cartridge positioning during operation while enabling easy cartridge removal for refilling or replacement. The magnetic attachment system eliminates the need for complex mechanical locking mechanisms while ensuring reliable cartridge retention during the dynamic forces encountered during dispensing operations.
[0090] Integrated Dispensing Process and System Coordination
[0091] The cartridge architecture supports the system's physiologically-gated operation by ensuring that once biometric authentication through the common sensing channel 56 and physiological data capture have been successfully completed, the mechanical dispensing process delivers exactly the prescribed medication quantity. Upon the activation of the feeder gear assembly 68, the feeder lever 70 advances through the rear access port 74 to physically displace the bottommost pill from the vertical stack within the linear slot 81.
[0092] During dispensing, the rubber stopper 84 maintains retention of all pills except the one being actively dispensed, while the dispense sensor(s) 62 provides electronic confirmation of successful pill release. The transparent panel 82 enables pre- and postdispensing visual verification, while the dual-magnet attachment system ensures reliable cartridge positioning and secure connection to the main dispensing mechanism throughout the dispensing sequence.
[0093] Enhanced Modular Medication Compatibility
[0094] The cartridge system accommodates various medication forms and sizes through modular design principles, with standard Type 1 cartridges 58 configured for conventional tablets and capsules, and specialized Type 2 cartridge variants designed for blister-packed medications or unusually sized pharmaceutical formulations. The Type 2 cartridges feature enlarged internal dimensions and modified dispensing mechanisms to accommodate blister strips, bubble packs, and other manufacturer packaging formats without requiring medication removal from original packaging. The enlarged linear slot 81 extends both laterally and vertically to provide sufficient clearance for blister pack thickness variations, while the feeder gear assembly 68 incorporates a modified lever head 72 with broader contact geometry designed to engage with packaged medication units rather than individual pills. The specialized dispensing mechanism for blister-packaged medications maintains the system's core physiologically-gated operation while ensuring complete package integrity throughout the dispensing process. Enhanced dispense sensors 62 provide confirmation signals specific to blister unit passage, with detection algorithms that differentiate between complete blister dispensing and potential packaging failures. Each cartridge 58 maintains its mechanical integrity and single-unit dispensing precision regardless of medication packaging format through the coordinated function of the linear guide 88, specialized stopper mechanisms, and magnetic attachment system, ensuring consistent operation across diverse pharmaceutical presentations while maintaining the critical linkage between successful physiological data acquisition through the common sensing channel 56 and authorized medication access.
[0095] Operational Sequence and Physiologically-Gated Dispensing Process
[0096] Scheduled Medication Trigger and User Authentication
[0097] Referring to FIGs. 2 through 6, the device 12 initiates the physiologically-gated dispensing sequence based on predetermined medication schedules stored within the memory 34 and coordinated through the cloud-based server system 14. When the processor 24 determines that a scheduled medication time has arrived, the device 12 activates multiple user notification systems to alert the patient of the pending medication requirement. The speaker 38 emits audible alarm signals while the LEDs 44 provide visual status indicators, with both notification modalities continuing for a predetermined duration in repetitive cycles until user interaction is detected or a timeout condition is reached.
[0098] Upon detecting the scheduled medication trigger, the display 36, in one embodiment, presents user prompts directing the patient to interact with the common sensing channel 56 for combined authentication and physiological data acquisition. The processor 24 simultaneously activates both the fingerprint sensor 20 and the physiological data sensor 22 within the common sensing channel 56, preparing the system for the mandatory dualsensor verification process that serves as the prerequisite for medication dispensing authorization.
[0099] Integrated Biometric Verification and Physiological Parameter Capture
[0100] When the user places their fingertip within the common sensing channel 56, the fingerprint sensor 20 captures biometric authentication data while the physiological data sensor 22 simultaneously records vital parameters including heart rate variability (HRV), oxygen saturation (SpCh), and maybe pulse characteristics. The processor 24 processes the authentication credentials by comparing the captured fingerprint data against prestored biometric templates stored within the memory 34, while concurrently analyzing the physiological parameters for data quality validation and optional safety threshold evaluation.
[0101] The integrated dual-sensor configuration ensures temporal and identity synchronization, with both biometric and physiological data acquisition occurring during the same finger contact event and assigned identical session identifiers and timestamps. The system incorporates alternative session management approaches including proximity-based session management with RFID / NFC tokens for session identification, blockchain session tracking for immutable session logging with distributed verification, and enhanced session correlation systems that maintain comprehensive audit trails of all authentication and physiological data acquisition events.
[0102] The processor 24 validates successful authentication by confirming biometric match criteria while simultaneously verifying that physiological parameter readings meet minimum signal quality requirements, ensuring that both identity verification and vital signs data capture are completed satisfactorily before proceeding to the dispensing authorization phase.
[0103] In embodiments implementing safety monitoring protocols, the processor 24 evaluates the captured physiological parameters against predefined threshold ranges specific to the scheduled medication type, enabling the system to identify potentially contraindicated physiological conditions that may warrant healthcare provider notification or dispensing delay. Upon successful completion of both authentication and physiological data acquisition, the processor 24 stores the session data within the memory 34 for subsequent transmission to the cloud-based server system 14 and authorizes progression to the medication dispensing phase.
[0104] Prescription Validation and Cartridge Activation
[0105] Following successful authentication and physiological data capture, the processor 24 retrieves the current medication schedule from the memory 34 and identifies the specific cartridge 58 containing the prescribed medication for the current dispensing session. The processor 24 cross-references the scheduled medication parameters including medication type, dosage quantity, and timing requirements against the authenticated user profile to ensure prescription accuracy and prevent unauthorized medication access.
[0106] The device 12 incorporates multiple cartridges 58 positioned within individual cartridge receiving bays 59, with each cartridge 58 maintaining its secure magnetic attachment through the dual neodymium magnet configuration while remaining electronically addressable through the processor 24. Upon identifying the target cartridge 58 for the current dispensing session, the processor 24 activates the corresponding feeder gear assembly 68 and prepares the associated Dispense sensor 62 for pill release verification.
[0107] Mechanical Dispensing Process and Single-Pill Control
[0108] The processor 24 initiates the mechanical dispensing sequence by energizing the motor 46 associated with the feeder gear assembly 68, causing controlled rotation of the gear mechanism that drives the feeder lever 70 in a forward motion toward the target cartridge 58. The feeder lever 70 extends through the rear access port 74 of the cartridge 58, with the lever head 72 making physical contact with the bottommost pill within the vertical stack contained in the linear slot 81.
[0109] The controlled advancement of the feeder lever 70 applies precise mechanical force to displace the bottommost pill from the stack while the rubber stopper 84 maintains retention of the remaining pills above, preventing multiple pill release during the single dispensing activation. The displaced pill travels through the pill outlet 86 of the cartridge 58 and enters the pill drain pathway 64, utilizing gravity-assisted flow to transport the medication to the collection area 66.
[0110] The Dispense sensor 62 positioned along the pill drain pathway 64 detects the passage of the dispensed pill, generating a confirmation signal that is transmitted to the processor 24 to verify successful pill release. Upon receiving the sensor confirmation, the processor 24 reverses the motor 46 rotation, causing the feeder gear assembly 68 to retract the feeder lever 70 to its initial position, thereby completing the mechanical dispensing cycle and preparing the system for subsequent dispensing operations.
[0111] Error Detection and Anti-Jamming Mechanisms
[0112] The device 12 implements comprehensive error detection protocols to identify and respond to dispensing failures including pill jamming, empty cartridge conditions, and mechanical malfunctions. The system incorporates alternative safety and error management approaches including predictive error detection with sensors detecting potential jams before they occur, self-diagnostic systems with automated mechanical testing and calibration, remote diagnostic capabilities with cloud-based analysis of device performance patterns, multi-level safety protocols with cascading safety checks and different intervention levels, and learning error prevention systems that adapt based on historical failure patterns to prevent recurring issues.
[0113] During each dispensing cycle, the processor 24 monitors the Dispense sensor 62 for pill passage confirmation within a predetermined time window following feeder lever 70 activation. If no pill detection occurs within the specified timeframe, the processor 24 identifies a dispensing failure condition and initiates error response protocols.
[0114] Upon detecting a dispensing failure, the processor 24 immediately halts the mechanical dispensing process and activates multiple notification systems including display 36 error messages, speaker 38 audio alerts, and LED 44 warning indicators. The processor 24 simultaneously generates error notifications transmitted through the communication modules including the Bluetooth module 26, Wi-Fi module 28, or cellular connectivity through the SIM circuit 30, alerting caregivers, healthcare providers, or authorized contacts of the dispensing malfunction.
[0115] The error notification system provides specific diagnostic information including cartridge identification, error type classification (jamming versus empty cartridge), and recommended corrective actions. For pill jamming conditions, the system guides users through cartridge removal procedures and manual jam clearance protocols, while empty cartridge notifications include refill instructions and cartridge replacement procedures. The processor 24 maintains error logs within the memory 34 for transmission to the cloudbased server system 14, enabling remote monitoring and maintenance scheduling.
[0116] Emergency Manual Control and Power-Independent Access System
[0117] The medication dispensing system 10 incorporates critical emergency manual control mechanisms designed to ensure continuous medication access during power failures, system malfunctions, or other emergency situations where electronic operation is compromised. The device 12 includes dedicated manual override switches 48 and mechanical bypass systems that operate independently of electrical power, enabling users to extract prescribed medications even when the battery 50 is depleted or electronic components are non-functional. The emergency manual control system comprises spring- loaded mechanical actuators positioned adjacent to each cartridge receiving bay 59, allowing direct manual activation of the feeder gear assembly 68 through purely mechanical force applied via emergency access switches located on the exterior housing of the device 12.
[0118] Upon activation of the emergency manual controls, users can bypass the normal physiologically-gated dispensing process by applying direct mechanical pressure to designated emergency switches, which engage mechanical linkages that manually advance the feeder lever 70 to dispense individual pills from the selected cartridge 58 without requiring electrical power, biometric authentication, or physiological data acquisition. The emergency manual dispensing mechanism maintains the single-pill dispensing precision of the automated system through the same rubber stopper 84 and mechanical gate arrangements, ensuring that even during emergency operation, users receive only the intended dosage quantity. Emergency access events are mechanically logged through simple counter mechanisms and automatically transmitted to the cloudbased server system 14 once power is restored, ensuring comprehensive documentation of all medication dispensing events including those occurring during system emergencies for clinical oversight and adherence monitoring purposes.
[0119] Automated Inventory Management and Restocking Protocol
[0120] The device 12 incorporates sophisticated inventory management capabilities that continuously monitor pill quantities within each cartridge 58 through a combination of dispensing event tracking and optical verification systems. When the processor 24 determines that the pills within a specific cartridge 58 are approaching depletion based on predetermined threshold parameters, the system initiates an automated restocking protocol that communicates with the cloud-based server system 14 to facilitate medication replenishment.
[0121] Upon detecting low inventory conditions, the processor 24 generates a restocking request that includes medication identification, remaining quantity, estimated depletion date, and user prescription details, which is transmitted to the cloud-based server system 14 through the available communication channels. The server system 14 processes the restocking request and, subject to user authorization and consent obtained through the client system 16, initiates communication with authorized pharmaceutical suppliers, pharmacies, or healthcare providers to place replenishment orders.
[0122] Preferably, the automated restocking protocol requires explicit user permission obtained through secure authentication channels, ensuring that medication orders are placed only with the patient's informed consent and in accordance with current prescription requirements. The system maintains comprehensive logs of all restocking activities, including order confirmations, delivery schedules, and cost tracking, which are accessible to users and healthcare providers through the client system 16 interfaces for transparency and financial management purposes.
[0123] Comprehensive Medication Information Database and Management System
[0124] The medication dispensing system 10 incorporates a sophisticated medication information database maintained within the memory 34 and synchronized with the cloudbased server system 14 to provide comprehensive tracking and management of detailed pharmaceutical parameters for each medication stored within the cartridges 58. The processor 24 maintains extensive medication records including generic medication names, complete compositional information specifying active pharmaceutical ingredients and excipients, manufacturer identification and producer company details, lot numbers and production batch information, brand-specific identifiers, and real-time pricing information synchronized with pharmaceutical supplier databases to enable accurate cost tracking per medication type and formulation.
[0125] The system implements proactive medication safety monitoring through automated expiry date tracking and alert generation, whereby the processor 24 continuously monitors stored expiration dates against current system time and generates graduated warning notifications through the display 36, speaker 38, and communication modules when medications approach or exceed expiration thresholds. This integrated medication information management capability ensures that healthcare providers, caregivers, and patients have immediate access to critical pharmaceutical data including composition details for allergy screening, manufacturer information for quality assurance, expiration status for safety compliance, and comprehensive cost information for financial planning, thereby supporting medication safety protocols and informed healthcare decision-making throughout the medication management lifecycle.
[0126] Integrated Financial Management and Budget Tracking System
[0127] In an additional embodiment, the medication dispensing system 10 incorporates comprehensive financial management capabilities designed to track, analyze, and report medication-related expenses, providing patients, caregivers, and healthcare providers with detailed cost information to support budget planning and healthcare financial management. The processor 24 maintains detailed medication cost databases within the memory 34, storing pricing information for each medication type, dosage, and supplier, enabling real-time cost calculations and expense tracking for every dispensing event.
[0128] The system automatically records the cost of each dispensed medication based on current pricing data retrieved from the cloud-based server system 14, which maintains up-to-date pharmaceutical pricing information from multiple suppliers and pharmacies. Upon each medication dispensing event, the processor 24 calculates the associated cost and updates the cumulative expense records stored within the memory 34, creating detailed financial logs that include medication name, dispensing date and time, quantity dispensed, unit cost, and total session cost.
[0129] The cloud-based server system 14 processes these financial data to generate comprehensive expense reports, budget analysis, and cost trend projections that are accessible to users through the client system 16 interfaces. The financial management system enables users to set monthly or annual medication budget limits, with the processor 24 configured to generate budget alerts and notifications when spending approaches or exceeds predefined thresholds.
[0130] The display 36 provides real-time cost information during medication dispensing sessions, showing current session cost, monthly cumulative expenses, and remaining budget availability to keep users informed of their medication-related financial status. In one embodiment, the system further supports insurance integration and co-payment tracking, automatically calculating patient responsibility amounts based on insurance coverage information stored within the user profile data.
[0131] Double Pill Dispensing Prevention and Verification
[0132] The device 12 employs multiple redundant mechanisms to prevent accidental double pill dispensing during single activation cycles. The primary prevention mechanism relies on the precise mechanical design of the rubber stopper 84 within the cartridge 58, which physically blocks the release of multiple pills by maintaining retention force on pills positioned above the dispensing position while allowing controlled release of the bottommost pill only.
[0133] The feeder lever 70 movement is calibrated to provide sufficient displacement force for single pill release while limiting stroke distance to prevent excessive mechanical disturbance of the pill stack within the linear slot 81. The processor 24, in one embodiment, controls the motor 46 operation with predetermined timing parameters that ensure single-stroke lever advancement and retraction, preventing extended mechanical contact that could potentially dislodge multiple pills simultaneously.
[0134] Electronic verification through the Dispense sensor 62 provides secondary double pill prevention by monitoring pill passage and detecting anomalous conditions such as multiple pill shadows or extended sensor activation periods that may indicate double pill release. Upon detecting multiple pill indicators, the processor 24 triggers error protocols and notifies users of potential over-dispensing conditions requiring manual verification and corrective action.
[0135] Multiple Pill Dispensing for Prescribed Dosages
[0136] When prescription requirements specify multiple pills of the same medication type to be dispensed during a single medication session, the processor 24 coordinates sequential dispensing operations through rapid succession activation of the feeder gear assembly 68. The processor 24 references the stored dosage parameters within the memory 34 to determine the required number of pill dispensing cycles for the current medication session.
[0137] For multiple pill dispensing, the processor 24 initiates the first dispensing cycle following the standard authentication and physiological data acquisition sequence, causing the feeder lever 70 to extend and dispense the first pill while the Dispense sensor 62 confirms successful release. Upon receiving confirmation of the first pill dispensing, the processor 24 immediately initiates a second dispensing cycle without requiring repeated user authentication, causing the feeder lever 70 to extend again in rapid succession to dispense the second pill from the same cartridge 58.
[0138] The rapid succession dispensing process maintains consistent timing intervals between individual pill releases while ensuring complete mechanical reset of the feeder lever 70 between cycles to prevent jamming or incomplete dispensing. The processor 24 continues sequential dispensing operations until the prescribed pill quantity has been released, with each individual pill passage verified by the Dispense sensor 62 before proceeding to the subsequent dispensing cycle.
[0139] Post-Dispensing Feedback Collection and Session Completion
[0140] Following successful completion of the prescribed medication dispensing, the processor 24 initiates the feedback collection phase to capture user responses and medication intake confirmation. The device 12 monitors the collection area 66 through optical sensing to detect pill removal by the user, with detection of pill collection triggering activation of the feedback collection window.
[0141] Upon detecting pill collection, the processor 24 activates a predetermined feedback time window during which the microphone 40, speaker 38, and user interface components including switches 48 become responsive to user input. The system incorporates alternative feedback and session management approaches including gesture-based feedback with motion sensors detecting hand gestures for status input, eye-tracking feedback with camera-based pupil tracking for non-contact feedback input, and haptic feedback systems with vibration patterns for user guidance and confirmation.
[0142] The feedback collection system prompts users through audio and visual cues to provide medication intake confirmation, subjective response ratings, or voice-recorded feedback regarding medication effects or side effects experienced.
[0143] The feedback time window remains active for a specified duration, typically ranging, say, from 30 seconds to 2 minutes depending on system configuration, during which users may interact with predefined feedback buttons or provide voice responses through the microphone 40. If no user feedback is received within the specified time window, the processor 24 automatically concludes the feedback session and transitions the device 12 to an idle state while logging the completed medication session data within the memory 34.
[0144] All collected feedback data, physiological parameters, authentication records, medication cost information, expense calculations, budget status updates, and dispensing logs are formatted by the processor 24 for transmission to the cloud-based server system 14 through available communication channels, ensuring comprehensive documentation of the complete medication session for healthcare provider review, adherence monitoring, and clinical outcome analysis. The completed session data enables longitudinal tracking of medication adherence patterns, physiological trends, expense trends, budget utilization patterns, and treatment response metrics that support personalized medication management and clinical decision-making processes.
[0145] Client System Architecture and Multi -Stakeholder Interface Implementation
[0146] Referring to FIGs. 7 through 9, the client system 16 comprises three distinct sub-systems designed to provide tailored interfaces and functionality for different stakeholders in the medication management ecosystem. Each sub-system operates through dedicated edge devices while maintaining seamless integration with the server system 14 and the medication dispensing device 12. The edge device may comprise a smartphone, a tablet, a PC wherein, the sub-systems are delivered to the user through a mobile application, a desktop application, a website, and / or the like.
[0147] Patient Sub-System Architecture
[0148] FIG. 7 illustrates the patient sub-system 90, which serves as the primary interface through which patients interact with the physiologically-gated medication dispensing system 10. The patient sub-system 90 comprises a patient UI 92 accessible through a patient edge device 94, with connectivity to the broader system architecture through internet 96 pathways that enable real-time communication with both the cloud-based server system 14 and the medication dispensing device 12.
[0149] The patient sub-system 90 incorporates nine core functional modules that collectively provide comprehensive medication management capabilities tailored to patient needs and preferences. An authentication & profile management module 98 enables secure access control through biometric profile setup encompassing fingerprint and facial recognition parameters, personal information management including demographics and medical history, contact information maintenance, and privacy settings configuration. The authentication & profile management module 98 interfaces directly with the common sensing channel 56 of the medication dispensing device 12 to ensure consistent biometric authentication protocols across the system architecture.
[0150] A medication management module 100 provides patients with comprehensive oversight of their medication regimens, enabling users to view current medication schedules and prescriptions, set custom dosage timing based on individual daily routines, perform manual medication logging and confirmation, track medication adherence statistics, and access detailed medication information including composition, expiry dates, and producer details. The medication management module 100 synchronizes directly with the processor 24 and memory 34 of the medication dispensing device 12 and the server system 14 to ensure real-time accuracy of medication schedule data and adherence tracking.
[0151] The notification & alert module 102 manages all patient-facing communications, delivering pill intake notifications and reminders, missed dose alerts, low medication stock warnings, device status notifications including battery and connectivity status, and budget alerts with expense notifications. The notification & alert module 102 coordinates with the speaker 38, display 36, and LEDs 44 of the medication dispensing device 12 to provide multi-modal alert delivery that ensures patient awareness of critical medication events.
[0152] A health monitoring & analytics module 104 provides patients with comprehensive access to their physiological data captured through the common sensing channel 56, enabling real-time physiological data viewing including HRV, SpCh, and heart rate parameters, physiological trend analysis and historical pattern recognition, medical progress report generation, and treatment insight delivery. The health monitoring & analytics module 104 receives physiological data directly from the physiological data recording sensor 22 through the cloud-based server system 14, ensuring patients have immediate access to their vital signs information following each medication dispensing event.
[0153] The device configuration module 106 enables patients to customize their medication dispensing experience through alarm settings including sound, volume, duration, and repetition parameters, display preferences configuration, and manual control with emergency access settings management. The device configuration module 106 interfaces with the processor 24 of the medication dispensing device 12 to implement user preferences in real-time, ensuring the system operates according to individual patient needs and circumstances.
[0154] A financial management module 108 provides comprehensive medication expense tracking and budget management capabilities, enabling patients to view medication costs and expense summaries, set budget parameters and track spending against established limits, and access cost trend analysis with financial projections. The financial management module 108 coordinates with the integrated financial management capabilities of the processor 24 to ensure accurate cost tracking and budget monitoring across all medication dispensing events.
[0155] The caregiver & communication module 110 facilitates patient control over their care network, enabling users to add, edit, or remove authorized caregivers, set caregiver notification preferences, manage emergency contact information, access teleconsultation interfaces with healthcare providers, and configure family sharing and collaborative care features. The caregiver & communication module 110 maintains secure communication pathways with both the caregiver sub-system 116 and healthcare professional sub-system 140 to ensure appropriate information sharing and care coordination. A feedback & reporting module 112 enables patients to provide comprehensive treatment feedback through post-medication feedback submission including button-based responses, voice recording capabilities for subjective feedback, camera integration for disease progression documentation, and treatment response tracking. The feedback & reporting module 112 interfaces directly with the microphone 40, camera 54, and switches 48 of the medication dispensing device 12 to capture patient input immediately following medication dispensing events.
[0156] The data synchronization module 114 ensures comprehensive data management and accessibility through cloud data backup and synchronization, cross-device data consistency maintenance, offline mode capabilities, and data export with sharing functions. The data synchronization module 114 coordinates with all communication modules of the medication dispensing device 12 including the Bluetooth module 26, WiFi module 28, and SIM circuit 30 to ensure reliable data transmission regardless of connectivity conditions.
[0157] Caregiver Sub-System Architecture
[0158] FIG. 8 details the caregiver sub-system 116, which provides authorized caregivers with comprehensive oversight and management capabilities for patient medication management. The caregiver sub-system 116 operates through a caregiver UI 118 accessible via caregiver edge devices 120, maintaining connectivity to the system architecture through the same internet 96 infrastructure that supports the patient subsystem 90.
[0159] The caregiver sub-system 116 comprises nine specialized functional modules designed to support caregiver responsibilities and enable effective patient oversight. A patient monitoring dashboard 122 provides real-time oversight capabilities including multipatient overview and status monitoring, real-time medication adherence tracking, physiological parameter monitoring with integrated alerting, critical health event notifications, and GPS-enabled patient location tracking when appropriate. The patient monitoring dashboard 122 receives data streams directly from the cloud-based server system 14, ensuring caregivers have immediate access to patient status information and can respond promptly to emerging healthcare needs.
[0160] A medication oversight module 124 enables caregivers to maintain direct involvement in patient medication management through medication schedule review and approval capabilities, missed dose and adherence pattern monitoring, automated alert reception for medication failures, dispensing permission override and modification authority, and emergency medication access authorization. The medication oversight module 124 interfaces with the processor 24 of the medication dispensing device 12 through the cloud-based server system 14, enabling caregivers to influence medication dispensing parameters in real-time while maintaining appropriate clinical oversight.
[0161] The health data analysis module 126 provides caregivers with comprehensive analytical capabilities including access to patient physiological trends and patterns, medication effectiveness indicator review, treatment response metrics monitoring, health summary report generation, and comparative analysis across multiple time periods. The health data analysis module 126 processes data captured by the physiological data recording sensor 22 and stored within the memory 34, presenting analytical insights that support caregiver decision-making and care coordination activities.
[0162] A communication & coordination module 128 facilitates comprehensive care team interaction through direct patient communication capabilities, healthcare provider collaboration interfaces, family member coordination and update systems, emergency notification protocols, and teleconsultation scheduling with participation features. The communication & coordination module 128 maintains secure communication pathways with both the patient sub-system 90 and healthcare professional sub-system 140, ensuring effective information flow across all care stakeholders.
[0163] The device management module 130 provides caregivers with technical oversight capabilities including remote device status monitoring, configuration management and update coordination, troubleshooting and technical support interface access, device maintenance scheduling, and backup with recovery operations management. The device management module 130 interfaces directly with the processor 24, memory 34, and communication modules of the medication dispensing device 12 to ensure optimal system performance and reliability.
[0164] A financial oversight module 132 enables caregivers to maintain appropriate financial supervision through patient medication expense monitoring, budget management and cost optimization, expense approval workflow management, and comprehensive financial reporting with analysis capabilities. The financial oversight module 132 coordinates with the financial management capabilities of the processor 24 to provide caregivers with transparent access to medication-related expenses and budget utilization patterns. The care planning module 134 supports long-term care coordination through medication schedule planning and optimization, treatment goal setting and tracking, care coordination with healthcare team members, medication transition management, and comprehensive long-term care planning tools. The care planning module 134 maintains integration with the healthcare professional sub-system 140 to ensure care plans align with clinical recommendations and treatment protocols.
[0165] An alert & notification management module 136 provides caregivers with comprehensive alert customization including alert preference and threshold configuration, escalation protocol establishment for critical events, multi-channel notification delivery through SMS, email, and application interfaces, alert acknowledgment and response tracking, and historical alert review with analysis capabilities. The alert & notification management module 136 coordinates with the notification & alert module 102 of the patient subsystem 90 to ensure appropriate alert distribution and response coordination.
[0166] The reporting & documentation module 138 enables comprehensive care documentation through care report generation, care intervention and outcome documentation, medication administration record maintenance, progress summary creation for healthcare providers, and compliance with regulatory reporting requirements. The reporting & documentation module 138 processes data from all system components to create comprehensive documentation that supports clinical decision-making and regulatory compliance.
[0167] Healthcare Professional Sub-System Architecture
[0168] FIG. 9 illustrates the healthcare professional sub-system 140, which provides clinical practitioners with comprehensive patient management, analytical, and decision support capabilities. The healthcare professional sub-system 140 operates through a professional UI 142 accessible via professional edge devices 144, maintaining the same internet 96 connectivity infrastructure while providing enhanced security and clinical workflow integration.
[0169] The healthcare professional sub-system 140 incorporates eleven specialized functional modules designed to support clinical practice and enable evidence-based patient care. A patient portfolio management module 146 provides comprehensive patient oversight through multi-patient dashboard interfaces with priority indicators, patient search and filtering capabilities, risk stratification with clinical alerting, population health analytics, and clinical workflow optimization. The patient portfolio management module 146 aggregates data from multiple medication dispensing devices 12 and associated physiological data recording sensors 22 to provide healthcare professionals with comprehensive patient population insights.
[0170] A prescription & treatment management module 148 enables comprehensive clinical decision support through electronic prescription creation and modification, medication schedule optimization, drug interaction checking with safety alerting, treatment protocol management, and integrated clinical decision support tools. The prescription & treatment management module 148 interfaces directly with the processor 24 and memory 34 of connected medication dispensing devices 12 to ensure prescribed medication regimens are accurately implemented and monitored.
[0171] The physiological data analytics module 150 provides advanced analytical capabilities including real-time vital signs monitoring, physiological trend analysis with pattern recognition, medication response correlation analysis, predictive analytics for adverse event identification, and clinical threshold management with alerting capabilities. The physiological data analytics module 150 processes data captured by physiological data recording sensors 22 across multiple patients to identify patterns, trends, and correlations that support clinical decision -making and treatment optimization.
[0172] A clinical documentation module 152 supports comprehensive clinical record-keeping through electronic health records integration, progress notes and treatment documentation, medication adherence documentation, clinical assessment tool integration, and regulatory compliance tracking. The clinical documentation module 152 maintains secure interfaces with existing healthcare information systems while incorporating medication dispensing and physiological monitoring data to provide comprehensive patient records.
[0173] The teleconsultation platform 154 enables remote patient care delivery through video consultation scheduling and management, real-time patient device data access during consultations, screen sharing and remote device control capabilities, consultation recording and documentation, and prescription modification during virtual visits. The teleconsultation platform 154 interfaces with the camera 54, microphone 40, and speaker 38 of the medication dispensing device 12 to facilitate comprehensive remote patient consultations with access to real-time physiological data.
[0174] A medication safety & monitoring module 156 provides comprehensive safety oversight through real-time medication safety alerting, adverse event detection and reporting, drug efficacy monitoring, dosage optimization recommendations, and safety protocol enforcement. The medication safety & monitoring module 156 continuously analyzes data from physiological data recording sensors 22 and medication dispensing events to identify potential safety concerns and optimize treatment protocols.
[0175] The research & analytics module 158 supports clinical research and quality improvement through clinical outcomes tracking, treatment effectiveness analysis, population health insights generation, research data export capabilities, and clinical trial patient identification. The research & analytics module 158 aggregates de-identified data from multiple medication dispensing systems 10 to support clinical research and evidencebased practice development.
[0176] A care coordination module 160 facilitates comprehensive healthcare team collaboration through team collaboration tools, care transition coordination, and multi-disciplinary care planning capabilities. The care coordination module 160 maintains secure communication pathways with caregiver sub-systems 116 and patient sub-systems 90 to ensure coordinated care delivery across all stakeholders.
[0177] The administrative & billing module 162 supports clinical practice management through billing code generation and management, treatment cost analysis, revenue cycle management, and regulatory reporting with compliance tracking. The administrative & billing module 162 integrates with the financial management capabilities of the system 10 to provide comprehensive cost analysis and billing support for medication management services.
[0178] A clinical alerts & intelligence module 164 provides comprehensive clinical decision support through critical patient status monitoring, medication adherence failure alerting, physiological parameter deviation warnings, system malfunction notifications, and clinical quality indicator tracking. The clinical alerts & intelligence module 164 processes data from all connected medication dispensing devices 12 and physiological data recording sensors 22 to provide healthcare professionals with real-time clinical intelligence and decision support.
[0179] The integration & interoperability module 166 ensures seamless healthcare system integration through electronic health record system integration, laboratory information system connectivity, pharmacy system integration, health information exchange participation, and third-party medical device integration capabilities. The integration & interoperability module 166 enables the healthcare professional sub-system 140 to function as part of comprehensive healthcare delivery systems while maintaining secure data exchange and clinical workflow integration.
[0180] The multi-tier client system architecture ensures that data captured through the physiologically-gated medication dispensing process, including biometric authentication records, physiological parameters, medication adherence data, and treatment response metrics, is accessible to appropriate stakeholders through role-based interfaces that support personalized care delivery, caregiver oversight, and clinical decision -making while maintaining comprehensive data security and patient privacy protection.
[0181] Method of Physiologically-Gated Medication Dispensing
[0182] Referring to FIGs. 10A through IOC, the comprehensive method of controlled dispensing of medication implemented by the medication dispensing system 10 is illustrated through a systematic operational flowchart that delineates the precise sequence of physiologically- gated dispensing operations. The method ensures that medication access is contingent upon successful completion of both biometric authentication and physiological data acquisition, thereby maintaining the critical linkage between user identity verification and contemporaneous health status monitoring.
[0183] Scheduled Trigger Detection and User Notification
[0184] The method commences at step 200 with the detection of a scheduled medication trigger based on predetermined medication schedules stored within the memory 34 and coordinated through the cloud-based server system 14. The processor 24 continuously monitors timing parameters and, upon determining that a prescribed medication administration time has arrived, initiates the dispensing sequence by proceeding to step 202 wherein user notification systems are activated. The activation of user notification systems 202 encompasses energizing the speaker 38 to emit audible alarm signals, illuminating the LEDs 44 to provide visual status indicators, and displaying user prompts on the display 36, with all notification modalities operating in repetitive cycles for a predetermined duration until user interaction is detected or a timeout condition is reached.
[0185] Following the activation of notification systems, the method proceeds to step 204 wherein the user is prompted to interact with the common sensing channel 56 for combined authentication and physiological data acquisition. The processor 24 simultaneously activates both the fingerprint sensor 20 and the physiological data sensor 22 within the common sensing channel 56, preparing the dual-sensor verification process that serves as the mandatory prerequisite for medication dispensing authorization.
[0186] Biometric Authentication and Session Management
[0187] The method advances to step 206 wherein the user is authenticated via biometric input through the common sensing channel 56. When the user places their fingertip within the common sensing channel 56, the fingerprint sensor 20 captures biometric authentication data while the processor 24 processes the authentication credentials by comparing the captured fingerprint data against pre-stored biometric templates maintained within the memory 34. The method then proceeds to decision step 208 to determine whether authentication was successful.
[0188] In the event that authentication is unsuccessful, the method branches to step 210 wherein an error notification is generated and the dispensing process is terminated. The processor 24 activates multiple notification systems including display 36 error messages, speaker 38 audio alerts, and LED 44 warning indicators, while simultaneously transmitting error notifications through the communication modules including the Bluetooth module 26, Wi-Fi module 28, or cellular connectivity through the SIM circuit 30 to alert caregivers, healthcare providers, or authorized contacts of the authentication failure.
[0189] Upon successful authentication, the method proceeds to step 212 wherein a session identifier and timestamp are assigned to the biometric authentication event. The processor 24 generates a unique session identifier that serves to temporally and identity-wise link all subsequent operations within the current dispensing cycle, ensuring comprehensive traceability and preventing credential spoofing or misattributed physiological data.
[0190] Physiological Data Acquisition and Validation
[0191] Following successful authentication and session initialization, the method advances to step 214 wherein physiological data of the user is acquired through the physiological data sensor 22 positioned within the common sensing channel 56. The physiological data sensor 22 simultaneously records vital parameters including heart rate variability (HRV), oxygen saturation (SpCh), and pulse characteristics during the same finger contact event that provided biometric authentication, thereby ensuring temporal and identity synchronization between authentication and physiological monitoring.
[0192] The method then proceeds to step 216 wherein the physiological data quality is verified and associated with the same session identifier and timestamp established in step 212. The processor 24 analyzes the physiological parameters for data quality validation, ensuring that physiological parameter readings meet minimum signal quality requirements and that both identity verification and vital signs data capture are completed satisfactorily before proceeding to the dispensing authorization phase.
[0193] Subsequently, the method advances to step 218 wherein the physiological data is utilized for at least one of: transmitting the data to an external entity, storing the data, or evaluating the data. In embodiments implementing safety monitoring protocols, the processor 24 evaluates the captured physiological parameters against predefined threshold ranges specific to the scheduled medication type, enabling the system to identify potentially contraindicated physiological conditions that may warrant healthcare provider notification or dispensing delay. Upon successful completion of physiological data acquisition and evaluation, the processor 24 stores the session data within the memory 34 for subsequent transmission to the cloud-based server system 14.
[0194] Medication Schedule Processing and Cartridge Selection
[0195] The method proceeds to step 220 wherein the medication schedule is retrieved from memory 34 and the specific cartridge 58 containing the prescribed medication for the current dispensing session is identified. The processor 24 references the stored medication schedule parameters including medication type, dosage quantity, and timing requirements, and identifies the target cartridge 58 from among the multiple cartridges 58 positioned within individual cartridge receiving bays 59. The processor 24 activates the corresponding feeder gear assembly 68 and prepares the associated Dispense sensor 62 for pill release verification.
[0196] Mechanical Dispensing Operation and Verification
[0197] Following cartridge identification and preparation, the method advances to step 222 wherein one or more medicines are dispensed through activation of the feeder gear assembly 68, execution of single-pill dispensing cycles, and verification of pill passage via the dispense sensor 62. The processor 24 initiates the mechanical dispensing sequence by energizing the motor 46 associated with the feeder gear assembly 68, causing controlled rotation of the gear mechanism that drives the feeder lever 70 in a forward motion toward the target cartridge 58. The feeder lever 70 extends through the rear access port 74 of the cartridge 58, with the lever head 72 making physical contact with the bottommost pill within the vertical stack contained in the linear slot 81. The method then proceeds to decision step 224 to determine whether dispensing was successful. The Dispense sensor 62 positioned along the pill drain pathway 64 detects the passage of the dispensed pill and generates a confirmation signal that is transmitted to the processor 24 to verify successful pill release. In the event that dispensing is unsuccessful, the method branches to step 226 wherein error detection and anti -jamming protocols are executed. The processor 24 immediately halts the mechanical dispensing process and activates multiple notification systems while generating error notifications that provide specific diagnostic information including cartridge identification, error type classification, and recommended corrective actions.
[0198] Upon successful dispensing verification, the method proceeds to step 228 wherein pill collection at the collection area 66 is detected. The device 12 monitors the collection area 66 through optical sensing to detect pill removal by the user, with detection of pill collection triggering progression to the feedback collection phase.
[0199] Post-Dispensing Feedback Collection and Session Completion
[0200] Following successful pill collection detection, the method advances to step 230 wherein a feedback unit is activated for a predefined duration. The processor 24 activates a predetermined feedback time window during which the microphone 40, speaker 38, and user interface components including switches 48 become responsive to user input. The feedback collection system prompts users through audio and visual cues to provide medication intake confirmation, subjective response ratings, or voice-recorded feedback regarding medication effects or side effects experienced.
[0201] The method then proceeds to step 232 wherein user feedback is collected or the feedback unit is automatically deactivated if no input is received within the predefined duration. The feedback time window remains active for a specified duration, typically ranging from 30 seconds to 2 minutes depending on system configuration, during which users may interact with predefined feedback buttons or provide voice responses through the microphone 40. If no user feedback is received within the specified time window, the processor 24 automatically concludes the feedback session and transitions the device 12 to an idle state.
[0202] Subsequently, the method advances to step 234 wherein complete session data is formatted and transmitted, encompassing physiological parameters, authentication records, dispensing logs, and feedback data. All collected feedback data, physiological parameters, authentication records, medication cost information, expense calculations, budget status updates, and dispensing logs are formatted by the processor 24 for transmission to the cloud-based server system 14 through available communication channels, ensuring comprehensive documentation of the complete medication session for healthcare provider review, adherence monitoring, and clinical outcome analysis.
[0203] Finally, the method proceeds to step 236 wherein session data is stored in memory 34 for subsequent transmission to the cloud-based server system 14, after which the method terminates. The completed session data enables longitudinal tracking of medication adherence patterns, physiological trends, expense trends, budget utilization patterns, and treatment response metrics that support personalized medication management and clinical decision-making processes, thereby completing the comprehensive physiologically-gated medication dispensing cycle while maintaining the critical integration of biometric authentication, physiological monitoring, and medication access control.
[0204] The foregoing detailed description demonstrates a comprehensive medication dispensing system that fundamentally advances the state of the art by mandatorily integrating realtime physiological data acquisition with biometric authentication as prerequisite conditions for medication access. Unlike conventional systems that operate solely on predetermined schedules or basic authentication protocols, the disclosed system creates an inextricable temporal and identity linkage between user verification, contemporaneous physiological status assessment, and medication dispensing authorization. The sophisticated integration of the common sensing channel 56, precision cartridge dispensing mechanisms with anti -jamming protocols, comprehensive multi-stakeholder client interfaces, and cloud-based analytics creates a holistic platform that addresses critical gaps in medication safety, adherence monitoring, and clinical oversight. The system's ability to capture, analyze, and transmit physiological parameters including heart rate variability and oxygen saturation immediately prior to each dispensing event, while maintaining comprehensive session tracking and financial management capabilities, establishes a new paradigm for medication management that is particularly valuable for high-risk therapies, chronic disease management, and remote patient monitoring applications. Through the seamless coordination of mechanical precision, electronic verification, biometric security, and physiological monitoring, the disclosed system provides healthcare stakeholders with unprecedented visibility into medication administration events while ensuring that therapeutic interventions occur only when patient identity is verified and physiological status is contemporaneously documented, thereby supporting personalized medicine approaches and evidence-based treatment optimization across diverse clinical settings. It should be understood that the arrangements, conditions, and components of the medication dispensing system 10 and physiologically-gated dispensing process illustrated in the accompanying figures are exemplary, and that other variations and embodiments are possible. It should also be understood that the various materials, components, configurations, and method steps defined by the claims, described above, and illustrated in the various figures represent embodiments configured according to the subject matter disclosed herein. For example, one or more of the specific materials, sensor types, electronic components, or communication protocols may be realized, in whole or in part, by variations described or encompassed by this disclosure. Although the present disclosure and its advantages have been described in detail, it should be understood that various changes, substitutions, and alterations can be made herein without departing from the spirit and scope of the present disclosure as defined by the appended claims.
Claims
We CLAIMSWhat is claimed is:
1. A medication dispensing system (10) comprising:(a) a medication dispensing device (12) configured to store and release at least one medication;(b) at least one physiological data recording sensor (22) configured to non-invasively obtain physiological data of a user; and(c) a control unit operatively coupled to the medication dispensing device (12), the control unit configured to:(i) receive the physiological data prior to initiating a dispensing cycle,(ii) utilize the physiological data for at least one of: transmitting the data to an external entity, storing the data, or evaluating the data, and(iii) initiate dispensing of the medication only after the physiological data has been obtained, and optionally generate a notification based on the physiological data.
2. The system (10) of claim 1, wherein the control unit is configured to compare the physiological data with at least one predefined condition and to prevent activation of the medication dispensing device (12) when the condition is not satisfied.
3. The system (10) of claim 2, wherein the predefined condition comprises at least one of: heart / pulse rate variability, oxygen saturation, heart rate, body temperature, or blood pressure.
4. The system (10) of claim 1, wherein the control unit is configured to authenticate the user via at least one biometric input selected from fingerprint recognition, facial recognition, or voice recognition, and to permit activation of the medication dispensing device (12) only upon successful authentication.
5. The system (10) of claim 4, wherein at least one sensor module is configured to acquire both biometric authentication data of the user and physiological data of the user through a common sensing interface or channel (56), thereby ensuring that the biometricauthentication and physiological data are captured from the same person during a common acquisition event.
6. The system (10) of claim 5, wherein the common sensing channel (56) comprises a fingerprint slot housing both a fingerprint sensor (20) and at least one physiological data recording sensor (22), such that biometric authentication and physiological data are obtained from the same finger placement event.
7. The system (10) of claim 4, wherein the control unit is configured to:(a) assign a session identifier and timestamp to a biometric authentication event,(b) acquire physiological data within a predefined time interval following the biometric authentication event, and(c) permit dispensing only when the biometric authentication data and the physiological data are associated with the same session identifier and fall within said time interval.
8. The system (10) of claim 1, wherein the medication dispensing device (12) comprises one or more cartridges (58), each configured to store a plurality of pills in a stacked arrangement, and wherein the control unit is further configured to select at least one cartridge (58) based on a prescribed medication schedule and to dispense one or more medicines from said selected at least one cartridge (58) in accordance with the schedule.
9. The system (10) of claim 8, wherein a cartridge (58) comprises:(a) a pill chamber (81) configured to receive and hold a column of pills,(b) a feeder gear assembly (68) including a feeder lever (70) arranged to advance only a single pill from the chamber during each dispensing cycle, and(c) a mechanical stopper or gate (84) positioned adjacent the outlet of the chamber, configured to block release of more than one pill at a time.
10. The system (10) of claim 9, wherein each cartridge (58) further comprises at least one dispense sensor (62) configured to detect the dispensing of a pill from said cartridge (58) and to provide a confirmation signal to the control unit to validate the completion of the dispensing cycle pertaining to said dispensed pill.
11. The system (10) of claim 10, wherein the control unit is configured to inhibit medication dispensing from the one or more cartridges (58) in the event of the at least one dispense sensor (62):(a) not detecting the dispensing of the pill within a predetermined time of the initiation of the dispensing cycle;(b) detecting simultaneous dispensing of more than one pill.
12. The system (10) of claim 1, wherein the control unit is configured to activate a feedback unit after a dispensing event, the feedback unit comprising at least one of predefined input buttons (48) for patient status selection, a microphone (40) for voice recording, or a camera (54) for image capture, and wherein the feedback unit is optionally configured to operate for a predefined duration after the dispensing event and to automatically deactivate if no input is received within said duration.
13. A method of controlled dispensing of medication, comprising:(a) acquiring physiological data of a user through at least one physiological data recording sensor (22);(b) utilizing the physiological data for at least one of: transmitting the data to an external entity, storing the data, or evaluating the data; and(c) dispensing one or more medicines only after the physiological data has been obtained.
14. The method of claim 13, further comprising authenticating the user via a biometric input through a fingerprint sensor (20) and permitting dispensing only upon successful authentication.
15. The method of claim 14, further comprising assigning a session identifier and timestamp to the biometric authentication event, acquiring physiological data within a predefined time interval following the authentication, and permitting dispensing only when both are associated with the same session identifier and fall within said time interval.
Citation Information
Patent Citations
System, method, and module for integrated medication management
EP3706705B1
Medication administration and adherence systems and related methods
US20200335192A1
Connected Pill Dispenser
US20200345587A1
Smart dispenser
US20240000665A1
Systems and methods for medication management
WO2020206154A1